Physician
Presbyterian Healthcare Services
Presbyterian Healthcare Services was paid $20.59M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoPRESBYTERIAN HEALTHCARE SERVICES
SOCORRO, NM 87801
SOCORRO, NM 87801
33aNPI1790761138assigned 12/19/2005
33bProvider typeEmergency Medicine Physician
28Total paid$20.59M
24GClaims257,056
24DCodes billed182
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in New Mexico
Rank by total paid#8 of 39
Median peer was paid$669K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,911 | $3.01M | |
| 2019 | 32,638 | $2.44M | |
| 2020 | 18,845 | $1.72M | |
| 2021 | 24,085 | $1.94M | |
| 2022 | 40,630 | $3.28M | |
| 2023 | 53,313 | $4.28M | |
| 2024incomplete | 42,634 | $3.92M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 21,214 | 19,708 | $4.34M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 17,737 | 16,566 | $4.11M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 10,098 | 9,135 | $3.28M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.5% | 4,123 | 3,980 | $711K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 1,212 | 1,169 | $626K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.6% | 6,832 | 5,406 | $530K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 4,813 | 4,166 | $385K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 2,440 | 2,339 | $359K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 3,998 | 3,490 | $347K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 1,323 | 1,268 | $328K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 3,623 | 1,264 | $239K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 1,487 | 1,308 | $237K |
170 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 652 | $233K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 1,082 | $228K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 3,111 | $219K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.0% | 3,877 | $214K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,991 | $182K |
| 87631 | <1% | 973 | $169K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,043 | $165K |
| G0378 | Hospital observation service, per hour | <1% | 235 | $155K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,274 | $153K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 981 | $149K |
| 80053 | Comprehensive metabolic panel | <1% | 10,065 | $138K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 558 | $133K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,219 | $123K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,462 | $119K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,013 | $118K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,286 | $112K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,283 | $111K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,831 | $101K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,015 | $92K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 487 | $74K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 612 | $71K |
| 73562 | <1% | 549 | $69K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,599 | $69K |
| 84484 | <1% | 3,012 | $69K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,204 | $61K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,132 | $56K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,183 | $56K |
| 83690 | <1% | 3,679 | $52K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 618 | $52K |
| 73610 | <1% | 351 | $49K | |
| 80306 | <1% | 1,552 | $47K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,763 | $47K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,809 | $43K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 807 | $43K |
| 73030 | <1% | 284 | $40K | |
| 84439 | <1% | 3,330 | $40K | |
| 87650 | <1% | 1,235 | $39K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 185 | $38K |
| 81025 | <1% | 3,086 | $38K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 337 | $37K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,084 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,831 | $37K |
| 73630 | <1% | 416 | $37K | |
| 81001 | <1% | 5,556 | $35K | |
| 80076 | <1% | 3,103 | $33K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 52 | $30K |
| 81513 | <1% | 190 | $28K | |
| 83605 | <1% | 1,845 | $27K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 761 | $27K |
| 96376 | <1% | 633 | $26K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,705 | $26K |
| 87040 | <1% | 1,019 | $25K | |
| 87077 | <1% | 1,853 | $25K | |
| 82728 | <1% | 1,293 | $24K | |
| 85027 | <1% | 2,339 | $22K | |
| 59025 | Fetal non-stress test | <1% | 103 | $22K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 40 | $21K |
| 86780 | <1% | 1,080 | $21K | |
| 87632 | <1% | 55 | $20K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 413 | $20K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 180 | $19K |
| J3490 | Unclassified drugs | <1% | 6,817 | $18K |
| 73130 | <1% | 184 | $17K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 55 | $17K |
| 87186 | <1% | 1,286 | $17K | |
| 83880 | <1% | 500 | $17K | |
| 80061 | Lipid panel | <1% | 1,086 | $17K |
| 82077 | <1% | 928 | $16K | |
| 86803 | <1% | 770 | $16K | |
| 83735 | <1% | 1,830 | $16K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 108 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 146 | $13K |
| 92557 | <1% | 88 | $13K | |
| 92567 | <1% | 229 | $13K | |
| 81003 | <1% | 2,853 | $13K | |
| 82962 | <1% | 1,543 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 287 | $11K |
| 82805 | <1% | 155 | $11K | |
| 85379 | <1% | 631 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 279 | $10K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 284 | $10K |
| 85610 | <1% | 1,429 | $9K | |
| 76830 | Ultrasound, transvaginal | <1% | 70 | $9K |
| 87081 | <1% | 724 | $9K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 664 | $9K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $9K |
| 94762 | <1% | 102 | $8K | |
| 87481 | <1% | 188 | $8K | |
| 36000 | <1% | 840 | $8K | |
| Q3014 | Telehealth originating site facility fee | <1% | 141 | $7K |
| 86140 | <1% | 1,206 | $7K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 178 | $7K |
| 86850 | <1% | 530 | $7K | |
| 87430 | <1% | 333 | $7K | |
| 84702 | <1% | 229 | $6K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,713 | $6K |
| 87480 | <1% | 177 | $5K | |
| 87510 | <1% | 177 | $5K | |
| 87660 | <1% | 177 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 88 | $5K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 441 | $5K |
| 81514 | <1% | 12 | $5K | |
| 86900 | <1% | 595 | $5K | |
| 90715 | <1% | 221 | $5K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,891 | $4K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 119 | $4K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $4K |
| 83550 | <1% | 333 | $4K | |
| 93976 | <1% | 16 | $3K | |
| 82570 | <1% | 499 | $3K | |
| 86901 | <1% | 591 | $3K | |
| 83540 | <1% | 372 | $3K | |
| 87340 | <1% | 193 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,329 | $3K |
| 82043 | <1% | 396 | $3K | |
| 73110 | <1% | 26 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 152 | $3K |
| 86787 | <1% | 125 | $2K | |
| 72100 | <1% | 14 | $2K | |
| 80074 | <1% | 28 | $2K | |
| 10060 | <1% | 17 | $2K | |
| 87653 | <1% | 36 | $2K | |
| 86762 | <1% | 93 | $2K | |
| 85652 | <1% | 412 | $2K | |
| 87070 | <1% | 136 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,423 | $2K |
| 87075 | <1% | 64 | $1K | |
| 80143 | <1% | 67 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 12 | $1K |
| 96367 | <1% | 28 | $1K | |
| 83655 | <1% | 62 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 324 | $1K |
| 80179 | <1% | 56 | $1K | |
| 97161 | <1% | 38 | $1K | |
| 97162 | <1% | 12 | $1K | |
| 87205 | <1% | 135 | $893.15 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 45 | $867.31 |
| 84703 | <1% | 62 | $866.64 | |
| 82550 | <1% | 108 | $858.05 | |
| 82010 | <1% | 74 | $796.07 | |
| 87807 | <1% | 38 | $744.52 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 575 | $727.80 |
| 82607 | <1% | 48 | $696.35 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 121 | $613.19 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 318 | $595.89 |
| 82140 | <1% | 43 | $587.82 | |
| 81002 | <1% | 183 | $553.27 | |
| 83516 | <1% | 24 | $544.55 | |
| 90670 | <1% | 43 | $510.41 | |
| 11721 | <1% | 23 | $502.30 | |
| 82947 | <1% | 65 | $398.21 | |
| 86038 | <1% | 28 | $386.31 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 74 | $259.94 |
| 80050 | General health panel | <1% | 14 | $252.88 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 187 | $238.63 |
| 82375 | <1% | 15 | $228.29 | |
| 94760 | <1% | 15 | $227.17 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 58 | $155.58 |
| 82784 | <1% | 15 | $142.24 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 46 | $122.39 |
| G0008 | Administration of influenza virus vaccine | <1% | 29 | $98.67 |
| 86431 | <1% | 14 | $92.84 | |
| 85018 | <1% | 14 | $60.24 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 12 | $54.94 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 52 | $48.98 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 85 | $44.77 |
| Q2039 | Influenza virus vaccine, not otherwise specified | <1% | 13 | $43.61 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 18 | $25.09 |
| J1815 | Injection, insulin, per 5 units | <1% | 38 | $8.27 |
| 97799 | <1% | 25 | $0.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARMIGNANI, VICTORIA (REGULATORY COMPLIANCE)
| Provider | Location | Paid |
|---|---|---|
| Presbyterian Healthcare Services | Socorro, NM | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.